Labrador, Prescila F.

HRN: 29-34-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/27/2026
08/03/2026
IVTT
4.5
QH
INTRAABDOMINAL INFECTION
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: